Zobrazeno 1 - 10
of 70
pro vyhledávání: '"N I, Ponomareva"'
Autor:
J. V. Roumiantseva, A. I. Karachunsky, O. V. Aleinikova, L. G. Fechina, A. V. Schamardina, D. V. Litvinov, N. I. Ponomareva, E. G. Boichenko, L. V. Sidorenko, S. A. Dudkin, O. V. Streneva, K. L. Kondratchik, E. G. Mansurova, L. M. Minkina, E. S. Lapotentova, E. V. Inuschkina, N. B. Yudina, G. P. Pavlova, E. V. Zhukovskaya, O. P. Chlebnikova, S. N. Lagoiko, E. V. Bascharova, R. E. Denisov, V. D. Zlobina, E. S. Banschikova, K. S. Aslanyan, E. V. Kondakova, E. V. Celousova, N. V. Myakova, T. V. Turobova, O. V. Riskal, N. F. Chipsanova, S. R. Varfolomeeva, A. G. Rumiantsev
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 37-49 (2022)
Проанализирована значимость прогностических факторов эффективности терапии у детей с острым лимфобластным лейкозом (ОЛЛ), получающих
Externí odkaz:
https://doaj.org/article/60da326014b14be09d19043fc252c8e4
Autor:
E. G. Boychenko, J. V. Rumyantseva, N. I. Ponomareva, M. S. Livschiz, I. A. Garbusova, M. B. Belogurova, L. I. Schaz, D. V. Litvinov, S. N. Lagoiko, K. L. Kondratchik, N. R. Tukalova, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 25-35 (2022)
In present article comparative efficacy analysis of two conceptually various acute lymphoblastic leukemia (ALL) chemotherapy programs from 18. 04. 2002 till 01. 01. 2007 aimed at definition of optimum ALL chemotherapy strategy in children is presente
Externí odkaz:
https://doaj.org/article/f86cdf617a30457fa1bdffdac13cacb4
Autor:
E. G. Boichenko, E. M. Petrova, M. B. Ivanovskaya, I. A. Garbusova, M. B. Belogurova, G. G. Radulesku, Yu. V. Roumiantseva, D. V. Litvinov, S. N. Lagoiko, K. L. Kondratchik, N. I. Ponomareva, N. R. Tukalova, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 12-21 (2022)
Comparative retrospective analysis of treatment results of three different chemotherapy protocols - ALL BFM 90m, ALL MB 91 and PECO 92 — in primary ALL patients aged before 18 years, registered in Moscow and St-Petersburg clinics from 01.01.1993 to
Externí odkaz:
https://doaj.org/article/d12d41e8fa8840ca9152f851f59db814
Autor:
Y Y DYAKONOVA, O I BYDANOV, A M POPOV, Y V OLSHANSKAYA, E G BOICHENKO, O V ALEYNIKOVA, M A MASCHAN, L N SHELIKHOVA, D V LITVINOV, L A KHACHATRYAN, N I PONOMAREVA, L G FECHINA, G A NOVICHKOVA, E D PASHANOV, A I KARACHUNSKIY
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 37-50 (2018)
Aim. The analysis of experience of nelarabine use in refractory/relapsed T-cell acute lymphoblastic leukemia (T-ALL) depending on the immunophenotype and the line of therapy. Materials and methods. All the patients with relapsed or refractory T-ALL a
Externí odkaz:
https://doaj.org/article/8277c105b38f465fa2bd4074aac1eb65
Autor:
A. P. Kostyusheva, S. A. Brezgin, N. I. Ponomareva, I. A. Goptar, A. V. Nikiforova, V. I. Gegechkori, V. B. Poluektova, K. A. Turkadze, A. E. Sudina, V. P. Chulanov, D. S. Kostyushev
Publikováno v:
Molecular Biology. 56:816-822
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f0aa437aca2d0cd6de73440e2a5f1c8
https://doi.org/10.1134/s0026893322060097
https://doi.org/10.1134/s0026893322060097
Autor:
R. N. Suprun, Yu. V. Rumyantseva, O. I. Bydanov, L. I. Zharikova, S. N. Lagoiko, V. V. Lebedev, K. L. Kondratchik, E. A. Druy, E. G. Mansurova, T. V. Asekretova, O. E. Murashkina, O. V. Aleynikova, L. G. Fechina, G. V. Bykova, N. I. Ponomareva, N. V. Myakova, A. M. Popov, Yu. V. Olshanskaya, A. N. Kazakova, D. V. Litvinov, G. A. Novichkova, A. I. Karachunskiy
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:12-31
Introduction. Down syndrome (DS) is one of the most common chromosomal abnormalities. Children with DS have an increased risk of developing acute lymphoblastic leukemia (ALL). Standard therapy is usually used to treat ALL in children with Down syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f036e3dafc5f4f57b9d14b9e3cca4c8c
https://doi.org/10.21682/2311-1267-2022-9-3-12-31
https://doi.org/10.21682/2311-1267-2022-9-3-12-31
Autor:
S. A. Brezgin, A. P. Kostyusheva, N. I. Ponomareva, V. I. Gegechkori, N. P. Kirdyashkina, S. R. Ayvasyan, L. N. Dmitrieva, L. N. Kokoreva, V. P. Chulanov, D. S. Kostyushev
Publikováno v:
Molecular Biology. 56:713-722
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab0c628218cc72b03b0ea8c2d8dd9979
https://doi.org/10.1134/s0026893322050041
https://doi.org/10.1134/s0026893322050041
Autor:
E. A. Zerkalenkova, O. I. Illarionova, A. N. Kazakova, N. I. Ponomareva, L. V. Baydun, E. Yu. Osipova, M. E. Dubrovina, A. M. Popov, T. V. Konyukhova, S. A. Plyasunova, N. V. Myakova, A. A. Maschan, Yu. V. Olshanskaya
Publikováno v:
Онкогематология, Vol 11, Iss 2, Pp 21-29 (2016)
Lineage switch is a rare phenomenon in which a transition from lymphoid to myeloid was observed in relapse of acute leukemia, or vice versa. This paper presents the four clinical case reports of acute lymphoblastic leukemia with MLL gene rearrangemen
Externí odkaz:
https://doaj.org/article/1cb2879f77984511ab1e04d6a383de28
Autor:
A. V. Lopatin, A. Yu. Kugushev, N. S. Grachev, S. A. Yasonov, N. I. Ponomareva, D. V. Rogozhin, A. V. Pshonkin
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 20:168-177
Melanotic neuroectodermal tumor of infancy is a rare neoplasm that predominantly involves cranial bones and tends to occur during the first year of life. About 500 cases have been described in the literature to date; 6% of them have been reported to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec058ab1475a29240d0633a9877461fb
https://doi.org/10.24287/1726-1708-2021-20-4-168-177
https://doi.org/10.24287/1726-1708-2021-20-4-168-177
Autor:
N. V. Smirnova, N. V. Myakova, M. B. Belogurova, O. V. Ryskal, O. E. Nikonova, G. R. Sharapova, A. S. Fedorova, N. A. Grigorieva, A. V. Shamardina, N. I. Ponomareva, D. S. Abramov, D. M. Konovalov, M. E. Dubrovina, A. A. Maschan, E. V. Samochatova
Publikováno v:
Онкогематология, Vol 10, Iss 4, Pp 15-24 (2015)
The results of two consecutive multicenter clinical trials enrolled 241 patient with childhood mature B-cells non-Hodgkin lymphomas/leukemia are presented. Patients received treatment according B-NHL 2004mab protocol (n = 83) and B-NHL 2010M (n = 158
Externí odkaz:
https://doaj.org/article/469abc7ec64f446c93dbb0d22210eeb6